Sign up


Match Document Document Title
8586062 Nanodispersion  
The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles...
8580281 Medicated patch  
Provided is a medicated patch containing a medicinal agent and an adhesive base material and having an acid value of no greater than 28, where the medicinal agent is varenicline or a...
8580296 Pharmacokinetics of S-adenosylmethionine formulations  
Compositions and methods to improve the pharmacokinetic profile of S-Adenosylmethionine (SAMe) are provided, as are methods of treating various disorders using SAMe formulations with improved...
8580856 Acetaminophen/ibuprofen combinations and method for their use  
A pharmaceutical dosage form is provided comprising a non-steroidal anti-inflammatory agent and acetaminophen, and methods for their use. In one embodiment, the dosage form is comprised of...
8580858 Compositions for the treatment of CNS-related conditions  
The invention provides compositions comprising extended release memantine in combination with immediate release donepezil to a subject. Memantine in an extended release form containing 22.5 to 30...
8580779 1,2-bis-sulfonamide derivatives as chemokine receptor modulators  
The present invention relates to novel bis-sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of...
8580282 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration  
The present invention relates to tetracaine based anesthetic formulations and methods of use thereof. The invention further relates to topical formulations of tetracaine and methods of topically...
8580846 Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders  
The invention is directed to a method of preventing or ameliorating a neuropsychiatric or neurodegenerative disease or disorder in a subject. The method includes administering a composition...
8580830 Non-mucoadhesive film dosage forms  
Orally disintegrating film dosage forms for delivering active pharmaceutical agents, methods of formulating the dosage forms to retard absorption through the oral mucosa, and methods of using the...
8574613 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof  
A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained...
8574600 Porous particles and cosmetics  
The invention provides porous particles, a process for producing the porous particles, and cosmetics comprising the porous particles. The porous particles of the invention have an average particle...
8574558 UV-curable nail coating formulations based on renewable polyols  
A photopolymerizable composition for forming a cosmetic coating for natural and artificial nails of humans and animals comprising a photoinitiator and a (meth)acrylate monomer prepared by reacting...
8574601 Sustained-release polymer micelle disruptable by HDL  
A pharmaceutical composition containing a drug encapsulated in a polymer micelle composition containing a first block copolymer having affinity with HDL and a second block copolymer having affinity...
8573198 Devices and methods for aerosol therapy using hyperbaric tonometry  
Methods and devices for creating a supersaturated liquid solution having dissolved gas with hyperbaric partial pressures and aerosolizing the supersaturated solution via a nebulizer. High partial...
8574559 Low-residue deodorant or antiperspirant stick based on an oil-in-water dispersion/emulsion  
Deodorant or antiperspirant sticks based on an oil-in-water dispersion/emulsion for application on the skin.
8574622 Controlled release delivery system for nasal applications  
This invention relates to a pernasally administrable preparation for the controlled release of sexual hormones to the systemic circulation, in particular to a formulation which enables its active...
8574628 Natural, multiple release and re-use compositions  
A composition comprising a biopolymer matrix, said biopolymer matrix comprising from about 0.1% to about 40% of an essential oil, about 30% to about 95% of a biopolymer, and about 0% to about 50%...
8574630 Corticosteroid particles and method of production  
A new particle morphology of glucocorticosteroids is described. The forms have a particle morphology that is particularly well suited for use in an inhaled corticosteroid drug suspension...
8568745 Water-soluble drug carrier and process for producing the same  
An object of the present invention is to provide a drug delivery carrier that is free from the drug leakage problem and has an easily controllable particle size, and that can be used to deliver...
8568747 Enalapril compositions  
Provided herein are stable enalapril powder compositions for oral liquid formulation. Also provided herein are methods of using enalapril oral liquid formulations for the treatment of certain...
8569315 Synergistic antimicrobial composition  
A synergistic antimicrobial composition comprising: (a) 3-iodo-2-propynyl-butylcarbamate; and (b) flumetsulam. A synergistic antimicrobial composition comprising: (a)...
8568704 Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer  
Topically applicable, dermatological/pharmaceutical compositions contain, formulated into a physiologically acceptable medium, benzoyl peroxide, at least one naphthoic acid compound and at least...
8568796 Pharmaceutical composition and method for reducing weight  
A pharmaceutical composition, particularly homeopathic medicines for weight reduction, including the following components: Adonis vernalis, Calcium carbonicum Hahnemann, Capsicum, Cascara, Fucus...
8568691 Methods for providing neuroprotection for the animal central nervous system against the effects of ischemia, neurodegeneration, trauma, and metal poisoning  
Methods and pharmaceutical compositions for providing neuroprotection to the animal central nervous system against the effects of ischemia, and neurodegeneration. Patients at risk for certain...
8568363 Frozen compositions and methods for piercing a substrate  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8568752 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation  
Disclosed is a method of brightening skin or evening out the tone of skin comprising topically applying to skin in need thereof a composition comprising a chemically compatible combination of one...
8568746 Transdermal composition of phosphatidylcholine and method for producing same  
Disclosed is a transdermal composition, which uses high-purity phosphatidylcholine that is most susceptible to oxidation and the like, and which exhibits high stability and high migration into the...
8563024 Biodegradable material components  
A biodegradable material for use in making items usable in surgery and related fields of medicine. The material comprising a bioabsorbable thermoplastic polymer component and a bioactive filler...
8563011 Use of low molecular weight amino alcohols in ophthalmic compositions  
The use of low molecular weight amino alcohols in ophthalmic compositions is described. These compounds have been found to enhance the efficacy of anti-microbial preservatives.
8563014 Modafinil oral lyophilizate  
The invention concerns an oral lyophilizate comprising modafinil particles having a median diameter of about 10 to about 1000 μm in association with an appropriate amount of at least one excipient ...
8563012 Compositions and methods for administering compartmentalized frozen particles  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8563010 Method for preventing mold formation by using hydrophobic materials, and mold-controlling agent for building parts  
The present invention relates to a method for suppressing mold formation on building parts using hydrophobic substances, wherein a dispersion of hydrophobic particles having a mean particle...
8562962 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation  
Disclosed is a topical skin composition, and methods for its use, comprising a chemically compatible combination of one or more surfactants and at least one chelating agent, an algae extract, and...
8562860 Method for activating and stabilizing dissolved hydrogen in water  
A method for activating hydrogen molecules dissolved in water and stabilizing the concentration of the hydrogen molecules is provided. The method for activating and stabilizing hydrogen molecules...
8563013 Systems and methods for delivering a fluid drug  
Devices and methods for distributing a fluid, e.g., a fluid drug, are disclosed. Fluid-drug distribution can be advantageously utilized to help patients suffering from a disorder that affect fine...
8563050 Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure  
The invention concerns a high water soluble product, containing a dehydrated material, obtained by fermenting wheat germ in aqueous medium in the presence of microorganisms of the Saccharomyces...
8557861 Low oil emulsion compositions for delivering taxoids and other insoluble drugs  
The present invention provides injectable oil-in-water emulsions of taxoid drugs or other water insoluble drugs. The present invention also provides methods for preparing and using such...
8557277 Medical products including modified extracellular matrix materials  
Described, in certain aspects, are medical products comprised of uniquely prepared remodelable extracellular matrix (ECM) materials retaining at least a portion of their native bioactivity. Also...
8557269 Paper tissue with high lotion transferability  
A paper tissue and products made from paper tissue, such as paper handkerchiefs, facial tissues, bath and cosmetic tissues, paper tissue wipes of any kinds and the like. The invention describes...
8557259 Liquid preparation  
It is an object of the present invention to provide a liquid preparation which excels in stability with no occurrence of precipitates and lees even after long storage. The liquid preparation...
8557260 Composition comprising at least two different cycloalkylmethicones and use thereof  
A cosmetic composition includes comprising a blend of cycloalkylmethicones comprising at least two different cycloalkylmethicones having general formula I: where R1 is a hydrocarbon radical...
8557870 Methods of treatment utilizing topical emulsion-gel composition comprising diclofenac sodium  
The invention relates to methods for treating burns or inflammation utilizing beneficial pharmaceutical compositions comprising diclofenac sodium salt in unusually low amounts. The compositions...
8557230 Cosmetic compositions containing block copolymers, tackifiers and shine enhancing agents  
A cosmetic composition containing at least one block copolymer having a hard segment and a soft segment, at least one tackifier component, at least one solvent, or solvent mixture, at least one...
8557280 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Stable pharmaceutical composition and methods of using same
 
The present invention relates to, inter alia, pharmaceutical compositions comprising a polyunsaturated fatty acid and to methods of using the same to treat or prevent cardiovascular-related diseases.
8551522 Sustained-release formulation  
A sustained-release formulation is provided comprising a solid dispersion composition comprising a tricyclic compound or a pharmaceutically acceptable salt thereof in a mixture comprising a...
8551528 Diketopiperazine microparticles with defined specific surface areas  
Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m2/g. The diketopiperazine microparticle can be fumaryl diketopiperazine and can comprise a...
8551525 Bone graft materials and methods  
Compositions, materials, methods and kits for bone grafting are described. In some embodiments, a bone graft composition includes about 15% to about 20% by weight collagen, about 55% to about 70%...
8551542 Methods and compositions for increasing growth hormones  
Embodiments of the invention generally relate to methods and supplements for improving the health of human beings.
8551505 Compositions and methods for therapeutic delivery with frozen particles  
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at...
8551917 Use of prolines for improving growth and/or yield  
The present invention describes a composition including a mixture of L- and D-pyroglutamate stereoisomers in a ratio of L to D of from about 80:20 to about 97:3, and, a carrier medium for...